316 related articles for article (PubMed ID: 34193368)
41. CO
Salvatore S; Pitsouni E; Grigoriadis T; Zacharakis D; Pantaleo G; Candiani M; Athanasiou S
Climacteric; 2021 Apr; 24(2):187-193. PubMed ID: 33089713
[TBL] [Abstract][Full Text] [Related]
42. Menopause leading to increased vaginal wall thickness in women with genital prolapse: impact on sexual response.
da Silva Lara LA; da Silva AR; Rosa-E-Silva JC; Chaud F; Silva-de-Sá MF; Meireles E Silva AR; de Sá Rosa-E-Silva AC
J Sex Med; 2009 Nov; 6(11):3097-110. PubMed ID: 19656272
[TBL] [Abstract][Full Text] [Related]
43. The Fractional CO
Li J; Li H; Zhou Y; Xie M; Miao Y; Wang L; Zhao Y; Ying T; Hu Y; Chen Y; Chen Y; Sun X; Wang J
Lasers Surg Med; 2021 Jul; 53(5):647-653. PubMed ID: 33211334
[TBL] [Abstract][Full Text] [Related]
44. Sexual function after vaginal erbium laser: the results of a large, multicentric, prospective study.
Gambacciani M; Albertin E; Torelli MG; Bracco GL; Casagrande AC; Martella L; Baiocchi G; Alfieri S; Russo N; Cervigni M;
Climacteric; 2020; 23(sup1):S24-S27. PubMed ID: 33124454
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause.
Barba M; Cola A; De Vicari D; Costa C; Castelli AP; Volontè S; Fruscio R; Frigerio M
Bioengineering (Basel); 2023 Oct; 10(10):. PubMed ID: 37892888
[TBL] [Abstract][Full Text] [Related]
46. The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis.
Jha S; Wyld L; Krishnaswamy PH
Clin Breast Cancer; 2019 Aug; 19(4):e556-e562. PubMed ID: 31227415
[TBL] [Abstract][Full Text] [Related]
47. Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes.
Sokol ER; Karram MM
Menopause; 2017 Jul; 24(7):810-814. PubMed ID: 28169913
[TBL] [Abstract][Full Text] [Related]
48. The impact of genitourinary syndrome of menopause on well-being, functioning, and quality of life in postmenopausal women.
Moral E; Delgado JL; Carmona F; Caballero B; Guillán C; González PM; Suárez-Almarza J; Velasco-Ortega S; Nieto Magro C;
Menopause; 2018 Dec; 25(12):1418-1423. PubMed ID: 29944636
[TBL] [Abstract][Full Text] [Related]
49. Effects of vaginal administration of conjugated estrogens tablet on sexual function in postmenopausal women with sexual dysfunction: a double-blind, randomized, placebo-controlled trial.
Bumphenkiatikul T; Panyakhamlerd K; Chatsuwan T; Ariyasriwatana C; Suwan A; Taweepolcharoen C; Taechakraichana N
BMC Womens Health; 2020 Aug; 20(1):173. PubMed ID: 32787848
[TBL] [Abstract][Full Text] [Related]
50. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society.
Portman DJ; Gass ML;
Maturitas; 2014 Nov; 79(3):349-54. PubMed ID: 25179577
[TBL] [Abstract][Full Text] [Related]
51. Sexual activity and function assessment in middle-aged Chinese women using the female sexual function index.
Zhang C; Cui L; Zhang L; Shi C; Zang H
Menopause; 2017 Jun; 24(6):669-676. PubMed ID: 28072610
[TBL] [Abstract][Full Text] [Related]
52. Microablative fractional CO
Pitsouni E; Grigoriadis T; Tsiveleka A; Zacharakis D; Salvatore S; Athanasiou S
Maturitas; 2016 Dec; 94():131-136. PubMed ID: 27823733
[TBL] [Abstract][Full Text] [Related]
53. MsFLASH network vaginal health trial: absence of evidence is NOT evidence of absence.
Lukas VA; Simon JA
Menopause; 2020 Jun; 27(6):722-725. PubMed ID: 32068684
[TBL] [Abstract][Full Text] [Related]
54. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning.
Pinkerton JV; Bushmakin AG; Komm BS; Abraham L
Maturitas; 2017 Jun; 100():57-63. PubMed ID: 28539177
[TBL] [Abstract][Full Text] [Related]
55. The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review.
Simon JA; Goldstein I; Kim NN; Davis SR; Kellogg-Spadt S; Lowenstein L; Pinkerton JV; Stuenkel CA; Traish AM; Archer DF; Bachmann G; Goldstein AT; Nappi RE; Vignozzi L
Menopause; 2018 Jul; 25(7):837-847. PubMed ID: 29870471
[TBL] [Abstract][Full Text] [Related]
56. The prevalence and determinants of genitourinary syndrome of menopause in Chinese mid-life women: a single-center study.
Geng L; Zheng Y; Zhou Y; Li C; Tao M
Climacteric; 2018 Oct; 21(5):478-482. PubMed ID: 29734845
[TBL] [Abstract][Full Text] [Related]
57. Patient-reported sexual function of breast cancer survivors with genitourinary syndrome of menopause after fractional CO2 laser therapy.
Quick AM; Zvinovski F; Hudson C; Hundley A; Evans C; Stephens JA; Arthur E; Ramaswamy B; Reinbolt RE; Noonan AM; VanDeusen JB; Wesolowski R; Stover DG; Williams NO; Sardesai SD; Faubion SS; Loprinzi CL; Lustberg MB
Menopause; 2021 Feb; 28(6):642-649. PubMed ID: 33534429
[TBL] [Abstract][Full Text] [Related]
58. Pelvic floor muscle rehabilitation for genitourinary syndrome of menopause: why, how and when?
Mercier J; Dumoulin C; Carrier-Noreau G
Climacteric; 2023 Aug; 26(4):302-308. PubMed ID: 37019140
[TBL] [Abstract][Full Text] [Related]
59. Assessing vaginal wall indexes in premenopausal versus postmenopausal women by transrectal linear array high-frequency probe.
Huang M; Wang Y; Xu J; Xiao H; Xie J
Eur J Med Res; 2023 Sep; 28(1):390. PubMed ID: 37770918
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
